ATE243696T1 - C-2 s/o- und s/n-formaldehydacetal-derivate von carbapenem-3-carbonsäuren und deren verwendung als antibiotika und beta-lactamas-inhibitoren - Google Patents

C-2 s/o- und s/n-formaldehydacetal-derivate von carbapenem-3-carbonsäuren und deren verwendung als antibiotika und beta-lactamas-inhibitoren

Info

Publication number
ATE243696T1
ATE243696T1 AT99936602T AT99936602T ATE243696T1 AT E243696 T1 ATE243696 T1 AT E243696T1 AT 99936602 T AT99936602 T AT 99936602T AT 99936602 T AT99936602 T AT 99936602T AT E243696 T1 ATE243696 T1 AT E243696T1
Authority
AT
Austria
Prior art keywords
inhibitors
derivatives
formaldehydacetal
lactamas
carbapenem
Prior art date
Application number
AT99936602T
Other languages
German (de)
English (en)
Inventor
Hans Rudolf Prof Pfaendler
Original Assignee
Hans Rudolf Prof Pfaendler
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hans Rudolf Prof Pfaendler filed Critical Hans Rudolf Prof Pfaendler
Application granted granted Critical
Publication of ATE243696T1 publication Critical patent/ATE243696T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT99936602T 1998-07-28 1999-07-23 C-2 s/o- und s/n-formaldehydacetal-derivate von carbapenem-3-carbonsäuren und deren verwendung als antibiotika und beta-lactamas-inhibitoren ATE243696T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98114067A EP0976752A1 (en) 1998-07-28 1998-07-28 C-2 S/O- and S/N-Formaldehyde acetal derivatives of carbapenem antibiotics
PCT/EP1999/005295 WO2000006574A1 (en) 1998-07-28 1999-07-23 NOVEL C-2 S/O- AND S/N FORMALDEHYDE ACETAL DERIVATIVES OF CARBAPENEM-3-CARBOXYLIC ACIDS AND THEIR USE AS ANTIBIOTICS AND β-LACTAMASE INHIBITORS

Publications (1)

Publication Number Publication Date
ATE243696T1 true ATE243696T1 (de) 2003-07-15

Family

ID=8232355

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99936602T ATE243696T1 (de) 1998-07-28 1999-07-23 C-2 s/o- und s/n-formaldehydacetal-derivate von carbapenem-3-carbonsäuren und deren verwendung als antibiotika und beta-lactamas-inhibitoren

Country Status (17)

Country Link
US (1) US6482818B2 (enExample)
EP (2) EP0976752A1 (enExample)
JP (1) JP4598273B2 (enExample)
KR (1) KR20010086351A (enExample)
CN (1) CN1154649C (enExample)
AT (1) ATE243696T1 (enExample)
AU (1) AU760249B2 (enExample)
CA (1) CA2338776C (enExample)
DE (1) DE69909098T2 (enExample)
ES (1) ES2203164T3 (enExample)
HU (1) HUP0102729A3 (enExample)
IL (1) IL141114A (enExample)
MX (1) MXPA01000905A (enExample)
NZ (1) NZ509578A (enExample)
PT (1) PT1100800E (enExample)
WO (1) WO2000006574A1 (enExample)
ZA (1) ZA200100737B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2576677A1 (en) * 2004-08-23 2006-03-02 Sicor, Inc. Synthesis of idarubin aglycone
JP5276653B2 (ja) 2007-05-21 2013-08-28 ハンス・ルドルフ・プフェンドラー カルバペネム類を含む殺菌性抗mrsa活性医薬組成物
CN101412718B (zh) * 2007-10-19 2011-04-27 山东轩竹医药科技有限公司 含有硫基杂环胺甲酰基的碳青霉烯衍生物
CN103059028B (zh) * 2013-01-30 2014-05-07 山东罗欣药业股份有限公司 一种替比培南匹伏酯的制备方法
CN114957258A (zh) * 2021-02-25 2022-08-30 华东理工大学 基于碳青霉烯结构的广谱丝氨酸β-内酰胺酶抑制剂的合成及其在耐药细菌抑制中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58116485A (ja) * 1981-12-29 1983-07-11 Shionogi & Co Ltd 新規抗生物質カルバペネム誘導体およびその製造法
GB2116540B (en) * 1981-11-10 1985-07-17 Shionogi & Co Pluracidomycin b c and d and analogs thereof their production and a microorganism for use therein
JPS58124785A (ja) * 1982-01-20 1983-07-25 Shionogi & Co Ltd プルラシドマイシンbおよびcのデオキシ体ならびにその製造法
JPS6054387A (ja) * 1983-08-03 1985-03-28 メルク エンド カムパニ− インコ−ポレ−テツド チエナマイシンの誘導体製造法
CA1285940C (en) * 1984-07-02 1991-07-09 Merck & Co., Inc. Carbapenems having a 2-quaternary heteroarylalkylthio substituent
IE851586L (en) * 1984-07-02 1986-01-02 Interchem Internat S A I methylcarbapenems having a 2-quaternary¹heteroarylalkylthio substituent
JPS63255283A (ja) * 1987-04-11 1988-10-21 Nippon Redarii Kk (1r,5s,6s)−2−〔(3−置換イミダゾリニウム−1−イル)アルキル〕チオ−6−〔(r)−1−ヒドロキシエチル〕−1−メチル−カルバペネム−3−カルボキシレ−ト
US5116833A (en) * 1990-10-19 1992-05-26 Bristol-Myers Squibb Company Antibiotic c-3 dithioacetal-substituted carbapenem compounds, compositions, and methods of use thereof

Also Published As

Publication number Publication date
HUP0102729A2 (hu) 2002-01-28
KR20010086351A (ko) 2001-09-10
JP4598273B2 (ja) 2010-12-15
PT1100800E (pt) 2003-11-28
AU5163999A (en) 2000-02-21
ZA200100737B (en) 2002-07-25
EP0976752A1 (en) 2000-02-02
IL141114A (en) 2004-02-08
CN1311790A (zh) 2001-09-05
EP1100800B1 (en) 2003-06-25
MXPA01000905A (es) 2002-06-04
AU760249B2 (en) 2003-05-08
EP1100800A1 (en) 2001-05-23
DE69909098D1 (de) 2003-07-31
CA2338776C (en) 2008-04-29
US20010031749A1 (en) 2001-10-18
NZ509578A (en) 2003-06-30
WO2000006574A1 (en) 2000-02-10
CN1154649C (zh) 2004-06-23
ES2203164T3 (es) 2004-04-01
IL141114A0 (en) 2002-02-10
HUP0102729A3 (en) 2002-09-30
CA2338776A1 (en) 2000-02-10
JP2002521484A (ja) 2002-07-16
US6482818B2 (en) 2002-11-19
DE69909098T2 (de) 2004-04-08

Similar Documents

Publication Publication Date Title
DE60315265D1 (de) Stickstoffhaltige heterocyclische verbindung und arzneimittel davon
NO970151L (no) Oksygeninneholdende heterocykliske forbindelser
AU6601294A (en) Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses
DE69906940D1 (de) Bizyclische pyrrolverbindungen, deren pharmazeutische zusammensetzungen und ihre verwendung als entzündungshemmende und immunmodulierende mittel
DK0976748T3 (da) Pyrrolidinderivater med phospholispase A2-hæmmende aktivitet
EP1008592A3 (en) Cyclic amide derivatives which inhibit cathepsin K
DK0916651T3 (da) Phenylalkylcarboxylsyrederivater
DE69909098D1 (de) C-2 s/o- und s/n-formaldehydacetal-derivate von carbapenem-3-carbonsäuren und deren verwendung als antibiotika und beta-lactamas-inhibitoren
KR870003992A (ko) 락탐 유도체, 그의 제조법 및 혈압강하제로의 이용
NO921159D0 (no) Tiazolidinon- og oksazolidinonderivater, fremgangsmaate til fremstilling derav, samt anvendelse av derivatene som vasodilatorer
DE69201184D1 (de) 5- Piperazinylalkyl-1,5-Benzothiazepinone verwendbar als Calciumantagonisten.
AU686104B2 (en) Substituted amidinonaphthyl ester derivatives
ATE375343T1 (de) Neue beta-lactamverbindungen und verfahren zu deren herstellung
ATE151750T1 (de) 3-(indol-3-yl) propensäurderivate, die als nmda- antagonisten nützlich sind
ATE258934T1 (de) Azaindol derivate und ihre verwendung als antithrombotische wirkstoffe
EP0779277A4 (en) 1,4-DIHYDROPYRIDINE DERIVATIVES
ES2188464T3 (es) Procedimiento para la obtencion de esteres de n-acil-aminoacidos y n-acil-aminoacetales.
DE69427100D1 (de) Herstellung von Beta-lactamverbindungen und Zwischenprodukte
EP1020440A4 (en) FOR THE PRODUCTION OF CARBAPENEM USEFUL INTERMEDIATE PRODUCTS AND METHOD FOR THEIR STEREOSELECTIVE SYNTHESIS
ATE148885T1 (de) Imidazopyridin-derivate und verfahren zu ihrer herstellung
DE69707793D1 (de) Alkynylaminosäure Derivate und ihre Verwendung als pharmazeutische Verbindungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1100800

Country of ref document: EP

REN Ceased due to non-payment of the annual fee